logo

MIRM

MirumยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MIRM Profile

Mirum Pharmaceuticals, Inc.

A biopharmaceutical company that develops novel therapies for cholestatic liveriseases

Pharmaceutical
05/02/2018
07/18/2019
NASDAQ Stock Exchange
322
12-31
Common stock
950 Tower Lane, Suite 1050, Foster City, California 94404
--
Mirum Pharmaceuticals, Inc., was incorporated in Delaware on May 2, 2018. The Company is a biopharmaceutical company focused on identifying, acquiring, developing and commercializing novel therapies for debilitating rare and orphan diseases.